Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 43, 2008, Pages 16743-16748

  Gack, Michaela U ^a,b,c   Kirchhofer, Axel ^d   Shin, Young C ^b   Inn, Kyung Soo ^a,b   Liang, Chengyu ^a,b   Cui, Sheng ^d   Myong, Sua ^e   Ha, Taekjip ^e   Hopfner, Karl Peter ^d   Jung, Jae U ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e University of Illinois at Urbana Champaign   (United States)

Author keywords

Alternative splicing; Innate immunity; Interferon

Indexed keywords

AMINO ACID; BETA INTERFERON; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; PEPTIDES AND PROTEINS; POLYUBIQUITIN; RETINOIC ACID INDUCIBLE PROTEIN I; THREONINE; TRIPARTITE MOTIF PROTEIN 25; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CYTOKINE PRODUCTION; EMBRYO; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; INNATE IMMUNITY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN VARIANT; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; VIRUS INFECTION;

CARD SIGNALING ADAPTOR PROTEINS; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; MUTATION; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; UP-REGULATION;

EID: 55949131282     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0804947105     Document Type: Article

References (26)

1. Hiscott J, Lin R, Nakhaei P, Paz S (2006) MasterCARD: A priceless link to innate immunity. Trends Mol Med 12:53-56.
2. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801.
3. Meylan E, Tschopp J, Karin M (2006) Intracellular pattern recognition receptors in the host response. Nature 442:39-44.
4. Creagh EM, O'Neill LA (2006) TLRs, NLRs and RLRs: A trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27:352-357.
5. Hornung V, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
6. Pichlmair A, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
7. Girardin SE, et al. (2003) Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300:1584-1587.
8. Girardin SE, et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869-8872.
9. Kawai T, Akira S (2007) Antiviral signaling through pattern recognition receptors. J Biochem 141:137-145.
10. Garcia-Sastre A, Biron CA (2006) Type 1 interferons and the virus-host relationship: A lesson in detente. Science 312:879-882.
11. Yoneyama M, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737.
12. Saito T, et al. (2007) Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 104:582-587.
13. Cui S, et al. (2008) The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol Cell 29:169-179.
14. Takahasi K, et al. (2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29:428-440.
15. Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
16. Kawai T, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988.
17. Meylan E, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
18. Xu LG, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727-740.
19. Sumpter R, Jr, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689-2699.
20. Gack MU, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
21. Arimoto K, et al. (2007) Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 104:7500-7505.
22. Rothenfusser S, et al. (2005) The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175:5260-5268.
23. Komuro A, Horvath CM (2006) RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J Virol 80:12332-12342.
24. Rosenstiel P, et al. (2006) A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci USA 103:3280-3285.
25. Leung E, Hong J, Fraser A, Krissansen GW (2007) Splicing of NOD2 (CARD15) RNA transcripts. Mol Immunol 44:284-294.
26. Janssens S, Burns K, Tschopp J, Beyaert R (2002) Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr Biol 12:467-471.